scispace - formally typeset
G

Gowthamarajan Kuppusamy

Researcher at Jagadguru Sri Shivarathreeswara University

Publications -  46
Citations -  1001

Gowthamarajan Kuppusamy is an academic researcher from Jagadguru Sri Shivarathreeswara University. The author has contributed to research in topics: Medicine & Drug delivery. The author has an hindex of 13, co-authored 35 publications receiving 565 citations.

Papers
More filters
Journal ArticleDOI

Curcumin loaded chitosan nanoparticles impregnated into collagen-alginate scaffolds for diabetic wound healing.

TL;DR: The present study suggests that the synergistic combination of CUR (anti-inflammatory and anti-oxidant), chitosan (sustain drug carrier, wound healing) and collagen (established wound healer as scaffold) is a promising strategy to address various pathological manifestations of diabetic wounds and have better wound healing capability.
Journal ArticleDOI

A review on novel vesicular drug delivery: proniosomes

TL;DR: Proniosomes overcome the demerits involved with niosomal and liposomal drug delivery systems and provide convenience in dosing, distribution, transportation and storage showing improved results than conventional niosomes.
Journal ArticleDOI

Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19

TL;DR: Curcumin, a bioactive compound in turmeric, exerts diverse pharmacological activities and is widely used in foods and traditional medicines as discussed by the authors, which suggest curcumin as a promising prophylactic, therapeutic candidate for COVID-19.
Journal ArticleDOI

Metformin in breast cancer: preclinical and clinical evidence.

TL;DR: Much more additional research is needed to confirm the accurate efficacy of metformin treatment for prevention of cancer and its recurrence, and a new pathway for improved understanding and successful application as repurposed effective chemotherapeutics for breast cancer is opened.
Journal ArticleDOI

Lipid-based nanocarriers for breast cancer treatment - comprehensive review.

TL;DR: The present review highlights the recently published studies in the development of lipid-based nanocarriers for breast cancer treatment as well as highlighting the emerging nanotechnologies exhibited the possibility to treat or target breast cancer.